Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) P/B ratio
As of 25 September 2026, Agilent Technologies, Inc. (A) trades at a P/B ratio of 6.6×. Over the past ten years it has ranged from 2.4× (January 2015) to 11.0× (September 2021); the current reading is higher than 72% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 6.2× | (3.76%) |
| FY2024 | 6.4× | 23.23% |
| FY2023 | 5.2× | (33.32%) |
| FY2022 | 7.8× | (11.99%) |
| FY2021 | 8.9× | 32.77% |
| FY2020 | 6.7× | 33.21% |
| FY2019 | 5.0× | 10.10% |
| FY2018 | 4.5× | 0.43% |
| FY2017 | 4.5× | 35.44% |
| FY2016 | 3.3× | 8.55% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jul 2026 | 5.3× | 15.83% |
| Apr 2026 | 4.6× | (17.51%) |
| Jan 2026 | 5.5× | (10.05%) |
| Oct 2025 | 6.2× | 20.46% |
| 43 more quarters | Free account |
Against its own ten years
Low 2.4×
High 11.0×
Ten-year median
5.4×
Current reading's percentile
72
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| WAT Waters Corporation compare | 2.8× |
| DGX Quest Diagnostics Incorporated compare | 3.4× |
| A Agilent Technologies, Inc. | 6.6× |
| IQV IQVIA Holdings Inc. compare | 7.1× |
| ILMN Illumina, Inc. compare | 14.5× |
| IDXX IDEXX Laboratories, Inc. compare | 25.4× |
| NTRA Natera, Inc. compare | 32.5× |
| MTD Mettler-Toledo International, Inc. compare | 2,372× |
| Diagnostics & Research industry median | 3.1× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement